Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Theseus Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 72
- +25 vs. Q4 2022
- Shares held
- 39.5M
- +6.41M (+19.4%) vs. Q4 2022
- Total value
- $350.6M
- +$185.8M (+112.7%) vs. Q4 2022
- New holders
- 27
- 22 more added
- Sold out
- 2
- 11 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 17,233,668 | $153.0M | 3.03% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 3,585,346 | $31.8M | 23.54% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,248,194 | $20.0M | 1.45% | +850,000+60.8% | Added |
| Fairmount Funds Management LLC | 1,865,671 | $16.6M | 2.85% | +1,865,671 | New |
| Paradigm Biocapital Advisors LP | 1,505,327 | $13.4M | 1.27% | +1,505,327 | New |
| Price T Rowe Associates Inc | 1,325,565 | $11.8M | 0.00% | +11,657+0.9% | Added |
| FMR LLC | 1,113,662 | $9.89M | 0.00% | −1,384,693−55.4% | Reduced |
| BlackRock Inc. | 883,462 | $7.85M | 0.00% | +18,405+2.1% | Added |
| VR Adviser, LLC | 770,000 | $6.84M | 1.34% | +770,000 | New |
| Lynx1 Capital Management LP | 761,258 | $6.76M | 5.64% | −22,900−2.9% | Reduced |
| Omega Fund Management, LLC | 711,479 | $6.32M | 4.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 700,961 | $6.22M | 0.00% | +62,489+9.8% | Added |
| Nextech Invest AG | 611,310 | $5.43M | 2.27% | 00.0% | Unchanged |
| Opaleye Management Inc. | 488,100 | $4.33M | 1.30% | −46,900−8.8% | Reduced |
| Citadel Advisors LLC | 484,386 | $4.30M | 0.00% | +484,386 | New |
| Janus Henderson Group PLC | 460,728 | $4.07M | 0.00% | +460,728 | New |
| Rock Springs Capital Management LP | 437,329 | $3.88M | 0.09% | 00.0% | Unchanged |
| Boxer Capital, LLC | 350,000 | $3.11M | 0.15% | −65,000−15.7% | Reduced |
| Geode Capital Management, LLC | 327,870 | $2.91M | 0.00% | +28,264+9.4% | Added |
| Candriam Luxembourg S.C.A. | 323,816 | $2.65M | 0.02% | +323,816 | New |
| State Street Corp | 296,864 | $2.64M | 0.00% | +25,383+9.3% | Added |
| Driehaus Capital Management LLC | 226,201 | $2.01M | 0.03% | +226,201 | New |
| Laurion Capital Management LP | 179,619 | $1.60M | 0.07% | 00.0% | Unchanged |
| Walleye Capital LLC | 179,550 | $1.59M | 0.03% | −18,697−9.4% | Reduced |
| Bank of America Corp | 179,202 | $1.59M | 0.00% | +164,582+1,125.7% | Added |
| Alliancebernstein L.P. | 154,317 | $1.37M | 0.00% | +154,317 | New |
| Woodline Partners LP | 143,980 | $1.28M | 0.02% | −90,022−38.5% | Reduced |
| Ensign Peak Advisors, Inc | 142,598 | $1.27M | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 133,460 | $1.19M | 0.00% | +159+0.1% | Added |
| DAFNA Capital Management LLC | 131,025 | $1.16M | 0.35% | +49,166+60.1% | Added |
| Renaissance Technologies LLC | 130,600 | $1.16M | 0.00% | +111,800+594.7% | Added |
| Altium Capital Management LP | 112,614 | $1.00M | 0.60% | +112,614 | New |
| Wellington Management Group LLP | 111,612 | $991.1K | 0.00% | +111,612 | New |
| UBS Oconnor LLC | 110,715 | $983.1K | 0.02% | +110,715 | New |
| TD Asset Management Inc | 106,948 | $949.7K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 100,000 | $888.0K | 0.79% | +100,000 | New |
| Affinity Asset Advisors, LLC | 98,221 | $872.2K | 0.34% | +98,221 | New |
| Millennium Management LLC | 80,035 | $711.0K | 0.00% | +80,035 | New |
| Manufacturers Life Insurance Company, The | 79,751 | $708.2K | 0.00% | +23,683+42.2% | Added |
| Schonfeld Strategic Advisors LLC | 78,369 | $695.9K | 0.01% | +78,369 | New |
| Tekla Capital Management LLC | 75,000 | $666.0K | 0.03% | −25,000−25.0% | Reduced |
| Two Sigma Investments, LP | 74,089 | $657.9K | 0.00% | +56,914+331.4% | Added |
| Bank of New York Mellon Corp | 51,862 | $460.5K | 0.00% | +8,369+19.2% | Added |
| Charles Schwab Investment Management Inc | 45,111 | $400.6K | 0.00% | +1,784+4.1% | Added |
| Morgan Stanley | 41,887 | $372.0K | 0.00% | +30,409+264.9% | Added |
| Hudson Bay Capital Management LP | 35,000 | $310.8K | 0.00% | +35,000 | New |
| Two Sigma Advisers, LP | 28,400 | $252.2K | 0.00% | +28,400 | New |
| Rhumbline Advisers | 25,822 | $229.0K | 0.00% | +820+3.3% | Added |
| Nuveen Asset Management, LLC | 21,849 | $194.0K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 18,081 | $160.6K | 0.00% | +18,081 | New |
| Gsa Capital Partners LLP | 17,543 | $156.0K | 0.02% | +17,543 | New |
| Jump Financial, LLC | 15,859 | $140.8K | 0.01% | +15,859 | New |
| JPMorgan Chase & Co | 13,037 | $116.0K | 0.00% | +3,398+35.3% | Added |
| Barclays PLC | 12,993 | $115.4K | 0.00% | +4,089+45.9% | Added |
| Deutsche Bank AG | 10,644 | $94.5K | 0.00% | +1,122+11.8% | Added |
| MetLife Investment Management | 10,330 | $91.7K | 0.00% | +10,330 | New |
| New York State Common Retirement Fund | 9,552 | $84.8K | 0.00% | +10.0% | Added |
| American International Group, Inc. | 8,201 | $72.8K | 0.00% | +164+2.0% | Added |
| UBS Group AG | 6,851 | $60.8K | 0.00% | +2,207+47.5% | Added |
| California State Teachers Retirement System | 6,317 | $56.1K | 0.00% | −466−6.9% | Reduced |
| Wells Fargo & Company | 3,007 | $26.7K | 0.00% | +3,007 | New |
| Advisor Group Holdings, Inc. | 2,793 | $24.8K | 0.00% | +2,793 | New |
| STRS Ohio | 2,700 | $23.0K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,796 | $16.0K | 0.00% | −105−5.5% | Reduced |
| Nisa Investment Advisors, LLC | 1,660 | $15.0K | 0.00% | +1,660 | New |
| Tower Research Capital LLC (TRC) | 1,418 | $13.0K | 0.00% | −3,732−72.5% | Reduced |
| Legal & General Group Plc | 1,433 | $12.7K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,126 | $10.0K | 0.00% | +1,126 | New |
| Royal Bank of Canada | 1,029 | $9.00K | 0.00% | −1,888−64.7% | Reduced |
| Ameritas Investment Partners, Inc. | 889 | $7.89K | 0.00% | 00.0% | Unchanged |
| Psagot Value Holdings Ltd. / (Israel) | 274 | $2.00K | 0.00% | +274 | New |
| Point72 Middle East FZE | 16 | $142 | 0.00% | +16 | New |
| Citigroup Inc | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |